2 results
Approved WMOWill not start
Evaluate the performance of the Agili-C in the repair of Cartilage and Osteochondral defects.
Approved WMORecruiting
Objectives of Part A, B and C are the following: Part A: determination of the optimal mass dose of S095012 to inject with 89Zr-S095012 and optimal time point for PET scans for appropriate visualisation of 89Zr-S095012 through PET imaging. Part B…